These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20849606)

  • 41. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.
    Kawamoto A; Tkebuchava T; Yamaguchi J; Nishimura H; Yoon YS; Milliken C; Uchida S; Masuo O; Iwaguro H; Ma H; Hanley A; Silver M; Kearney M; Losordo DW; Isner JM; Asahara T
    Circulation; 2003 Jan; 107(3):461-8. PubMed ID: 12551872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.
    Taniguchi N; Nakamura T; Sawada T; Matsubara K; Furukawa K; Hadase M; Nakahara Y; Nakamura T; Matsubara H
    Circ J; 2010 Nov; 74(11):2365-71. PubMed ID: 20834185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
    Ahmet I; Tae HJ; Juhaszova M; Riordon DR; Boheler KR; Sollott SJ; Brines M; Cerami A; Lakatta EG; Talan MI
    Mol Med; 2011; 17(3-4):194-200. PubMed ID: 21170473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
    Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
    Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis.
    Zhou L; Sung RY; Li K; Pong NH; Xiang P; Shen J; Ng PC; Chen Y
    Int J Cardiol; 2011 Oct; 152(2):196-201. PubMed ID: 20692056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
    Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
    Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells.
    Kang J; Yun JY; Hur J; Kang JA; Choi JI; Ko SB; Lee J; Kim JY; Hwang IC; Park YB; Kim HS
    Cardiovasc Res; 2014 Oct; 104(1):171-82. PubMed ID: 25082847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.
    Feygin J; Mansoor A; Eckman P; Swingen C; Zhang J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1772-80. PubMed ID: 17573463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells.
    Ryzhov S; Solenkova NV; Goldstein AE; Lamparter M; Fleenor T; Young PP; Greelish JP; Byrne JG; Vaughan DE; Biaggioni I; Hatzopoulos AK; Feoktistov I
    Circ Res; 2008 Feb; 102(3):356-63. PubMed ID: 18032734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel.
    Wang T; Jiang XJ; Lin T; Ren S; Li XY; Zhang XZ; Tang QZ
    Biomaterials; 2009 Sep; 30(25):4161-7. PubMed ID: 19539990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction.
    Gandia C; Armiñan A; García-Verdugo JM; Lledó E; Ruiz A; Miñana MD; Sanchez-Torrijos J; Payá R; Mirabet V; Carbonell-Uberos F; Llop M; Montero JA; Sepúlveda P
    Stem Cells; 2008 Mar; 26(3):638-45. PubMed ID: 18079433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-MI treatment with G-CSF and EPO-liposome with SLX repairs infarcted myocardium through EPCs mobilization and activation of prosurvival signals in rabbits.
    Yamada Y; Minatoguchi S; Endo N; Kanamori H; Kawasaki M; Nishigaki K; Mikami A; Minatoguchi S
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00451. PubMed ID: 30598826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model.
    Ben-Dor I; Hardy B; Fuchs S; Kaganovsky E; Kadmon E; Sagie A; Coleman R; Mansur M; Politi B; Fraser A; Harell D; Okon E; Battler A; Haim M
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):339-46. PubMed ID: 17912622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
    Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
    Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction.
    Zhang BF; Jiang H; Chen J; Hu Q; Yang S; Liu XP
    J Cell Physiol; 2019 Aug; 234(10):18544-18559. PubMed ID: 30982985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction.
    Kompa AR; Greening DW; Kong AM; McMillan PJ; Fang H; Saxena R; Wong RCB; Lees JG; Sivakumaran P; Newcomb AE; Tannous BA; Kos C; Mariana L; Loudovaris T; Hausenloy DJ; Lim SY
    Cardiovasc Res; 2021 Feb; 117(3):918-929. PubMed ID: 32251516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.